ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

High Cost, Low Efficiency Medicines

LATELY there has been an increasing trend of introducing new drugs at exorbitant costs. These drugs are basically molecular changes of older drugs. It is said that the Drug Controller of India (DCI) takes due care in introduction of new drugs. But from the following examples, one starts doubting the DCI intentions.

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top